Home | Welcome to Contract Pharma   
Last Updated Friday, May 22 2015


ICON Adds COO Role, Names Team Leaders

By Kristin Brooks

Published January 10, 2014
Related Searches: contractpharma Development Pharma www.contractpharma.com
Dr. Steve Cutler has been appointed to the newly created position of chief operating officer at ICON plc. Dr. Cutler will be responsible for the company’s operational units, covering Early Phase, Clinical, Laboratories, Commercialization and Outcomes and DOCS FSP & resourcing. Dr. Cutler will also be responsible for ICON’s sales and marketing and strategic alliance teams. He joined the company in November 2011 as group president, Clinical Research Services. 
Within Dr. Cutler’s team, Dr. Nuala Murphy has been appointed president, ICON Clinical Services, and Jim Miskel has been appointed executive vice president and general manager, ICON Laboratory Services. 
Dr. Murphy will oversee ICON’s global clinical services, including clinical and data operations, study start-up, project management, clinical risk management, technology services and clinical scientific operations. Dr. Murphy joined ICON in 2012 as executive vice president, Global Clinical Operations and Data Management.
Mr. Miskel will lead ICON’s newly combined Central and Bioanalytical laboratories group. He joined the company in November 2013 and brings extensive lab and pharma industry experience.
Ciaran Murray, chief executive officer of ICON, said, “We continually review our structure to ensure that as the market evolves, our organization can continue to provide customers with innovative and integrated solutions across our various service lines and business units. Bringing all operational units under Steve’s leadership will allow us to further enhance the support we can offer to our customers’ development programs. I would like to congratulate Steve, Nuala and Jim on their new roles and wish them every success in the future.”

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On